Literature DB >> 9164860

Two distinct uptake mechanisms for ascorbate and dehydroascorbate in human lymphoblasts and their interaction with glucose.

F C Ngkeekwong1, L L Ng.   

Abstract

In diabetes, a major cause of mortality is from cardiovascular causes, and low levels of antioxidants such as vitamin C have been associated with such complications. Leucocyte ascorbic acid status can reflect total body stores but the mechanisms that mediate the uptake of ascorbic acid (AA) or dehydroascorbic acid (DHA) in human lymphoid cells are undefined. We have investigated the uptake of AA and DHA with mass assays in human lymphoblasts by using HPLC, with precautions to prevent the oxidation of AA and to take into account the instability of DHA in buffers. Human lymphoblasts exhibit distinct uptake mechanisms for both AA and DHA, with Vmax values of 1.35+/-0.14 and 29.0+/-5.8 nmol/h per 10(6) cells and Km values of 23.5+/-6 and 104+/-84 microM respectively. The AA uptake was Na+-dependent and inhibitable with ouabain, whereas DHA uptake was independent of Na+ and ouabain-insensitive. Both uptake mechanisms were inhibited by phloretin or cytochalasin B. AA uptake was decreased significantly (by 13+/-2%) only at extracellular glucose concentrations of 20 mM (P<0.05). In contrast, glucose competitively inhibited DHA uptake with a Ki of 2.2 mM so that DHA uptake was decreased by glucose even in the physiological range. Phorbol esters stimulated AA but not DHA uptake; this was abolished in the presence of extracellular reductant, indicating that AA was converted to DHA before uptake occurred. Prolonged increased glucose levels (20 mM) led to a decrease in the Vmax of DHA uptake. At concentrations of plasma AA or DHA, the AA uptake mechanism might be nearly half-saturated but the DHA mechanism has enormous spare capacity. This allows for cellular uptake and regeneration of AA from DHA derived from oxidative stress. In diabetes, high glucose levels might impair DHA uptake acutely by competitive inhibition or by down-regulation of uptake with chronic glucose exposure, leading to an impaired ability to store and recycle oxidized AA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164860      PMCID: PMC1218420          DOI: 10.1042/bj3240225

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

Review 1.  New concepts in the biology and biochemistry of ascorbic acid.

Authors:  M Levine
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

Review 2.  Role of oxidative stress in development of complications in diabetes.

Authors:  J W Baynes
Journal:  Diabetes       Date:  1991-04       Impact factor: 9.461

3.  Plasma ascorbate concentrations and blood cell dehydroascorbate transport in patients with diabetes mellitus.

Authors:  L Stankova; M Riddle; J Larned; K Burry; D Menashe; J Hart; R Bigley
Journal:  Metabolism       Date:  1984-04       Impact factor: 8.694

Review 4.  Measurement of vitamin C in blood components by high-performance liquid chromatography. Implication in assessing vitamin C status.

Authors:  S T Omaye; E E Schaus; M A Kutnink; W C Hawkes
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

5.  Reduced mononuclear leukocyte ascorbic acid content in adults with insulin-dependent diabetes mellitus consuming adequate dietary vitamin C.

Authors:  J J Cunningham; S L Ellis; K L McVeigh; R E Levine; J Calles-Escandon
Journal:  Metabolism       Date:  1991-02       Impact factor: 8.694

Review 6.  Vitamin C and cardiovascular risk factors.

Authors:  D L Trout
Journal:  Am J Clin Nutr       Date:  1991-01       Impact factor: 7.045

7.  Ascorbic acid metabolism and polyol pathway in diabetes.

Authors:  D K Yue; S McLennan; E Fisher; S Heffernan; C Capogreco; G R Ross; J R Turtle
Journal:  Diabetes       Date:  1989-02       Impact factor: 9.461

8.  Inhibition of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by ascorbic acid. An effect mediated by the free radical monodehydroascorbate.

Authors:  H J Harwood; Y J Greene; P W Stacpoole
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157

9.  Release of glomerular heparan-35SO4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats.

Authors:  D J Klein; T R Oegema; D M Brown
Journal:  Diabetes       Date:  1989-01       Impact factor: 9.461

10.  Interaction of ascorbic acid and glucose on production of collagen and proteoglycan by fibroblasts.

Authors:  E Fisher; S V McLennan; H Tada; S Heffernan; D K Yue; J R Turtle
Journal:  Diabetes       Date:  1991-03       Impact factor: 9.461

View more
  5 in total

1.  Dehydroascorbic acid uptake in a human keratinocyte cell line (HaCaT) is glutathione-independent.

Authors:  I Savini; S Duflot; L Avigliano
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

2.  Interaction of respiratory burst and uptake of dehydroascorbic acid in differentiated HL-60 cells.

Authors:  H Laggner; H Goldenberg
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

3.  Dehydroascorbic acid uptake by coronary artery smooth muscle: effect of intracellular acidification.

Authors:  Melanie E Holmes; James Mwanjewe; Sue E Samson; James V Haist; John X Wilson; S Jeffrey Dixon; Morris Karmazyn; Ashok K Grover
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

4.  Recycling processes of cellular ascorbate generate oxidative stress in pancreatic tissues in in vitro system.

Authors:  Shelley Brown; Maria Georgatos; Conrad Reifel; Jih H Song; Seon H Shin; Murray Hong
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

5.  Ascorbate attenuates pulmonary emphysema by inhibiting tobacco smoke and Rtp801-triggered lung protein modification and proteolysis.

Authors:  Indranil Gupta; Souradipta Ganguly; Christine R Rozanas; Dennis J Stuehr; Koustubh Panda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-05       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.